Immunology of SARS-CoV-2 Infection

Biochemistry (Mosc). 2024 Jan;89(1):65-83. doi: 10.1134/S0006297924010048.

Abstract

According to the data from the World Health Organization, about 800 million of the world population had contracted coronavirus infection caused by SARS-CoV-2 by mid-2023. Properties of this virus have allowed it to circulate in the human population for a long time, evolving defense mechanisms against the host immune system. Severity of the disease depends largely on the degree of activation of the systemic immune response, including overstimulation of macrophages and monocytes, cytokine production, and triggering of adaptive T- and B-cell responses, while SARS-CoV-2 evades the immune system actions. In this review, we discuss immune responses triggered in response to the SARS-CoV-2 virus entry into the cell and malfunctions of the immune system that lead to the development of severe disease.

Keywords: ACE2 receptor; SARS-CoV-2; innate and adaptive immunity; membrane fusion; polymorphism; proteases; spike protein.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Humans
  • SARS-CoV-2